Mammary Analogue Secretory Carcinoma of Salivary Gland Origin: An Update and Expanded Morphologic and Immunohistochemical Spectrum of Recently Described Entity

Head and Neck Pathology

Volumn 7, Issue SUPPL 1, 2013, Pages 30-36

  Skalova, Alena ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

ETV6 NTRK3 fusion; Mammary analogue secretory carcinoma; MASC; Salivary gland

Indexed keywords

ETV6 NTRK3 FUSION PROTEIN, HUMAN; ETV6-NTRK3 FUSION PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

ACINAR CELL CARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; BREAST TUMOR; CARCINOMA; CYSTADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; SALIVARY GLAND TUMOR;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, ACINAR CELL; CARCINOMA, MUCOEPIDERMOID; CYSTADENOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS, FUSION; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880814215     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-013-0455-y     Document Type: Article

References (27)

1. Barnes L, Eveson J, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumours. World Health Organization classification of tumours. Lyon: IARC Press; 2005.
2. Gnepp DR, Henley JD, Simpson RHW, Eveson J. Salivary and Lacrimal glands. In: Gnepp DR, editors. Diagnostic surgical pathology of the head and neck. 2nd ed. Philadelphia: Saunders Elsevier, pp. 413-562.
3. Hunt JL. An update on molecular diagnostics of squamous and salivary gland tumors of head and neck. Arch Pathol Lab Med. 2011;135: 602-9.
4. McCord C, Weinreb I, Perez-Ordonez B. Progress in salivary gland pathology: new entities and selected molecular features. Diagnostic Histopathol. 2012;18(6): 253-60.
5. Skalova A, Vanecek T, Simpson RHW, Michal M. Molecular advances in salivary gland pathology and their practical application. Diagnostic Histopathol. 2012;18(9): 388-96.
6. Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RHW, Passador-Santos F, Ryska A, Leivo I, Kinkor Z, Michal M. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34: 599-608.
7. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Sorensen PHB. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2: 367-76.
8. Fehr A, Loning T, Stenman G. Mammary analogue secretory carcinoma of the salivary glands with ETV6-NTRK3 gene fusion. Letter to Editor. Am J Surg Pathol 2011; 35: 1600-1602.
9. Griffith C, Seethala R, Chiosea SI. Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Arch. 2011;459: 117-8.
10. Lei Y, Chiosea SI. Re-evaluating historic cohort of salivary acinic cell carcinoma with new diagnostic tools. Head and Neck Pathol. 2012;6: 166-70.
11. Connor A, Perez-Ordoñez B, Shago M, Skálová A, Weinreb I. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol. 2012;36: 27-34.
12. Chiosea SI, Griffith C, Assad A, Seethala RR. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol. 2012;36: 343-50.
13. Chiosea SI, Griffith C, Assad A, Seethala RR. Clinicopathological characterization of mammary analogue carcinoma of salivary glands. Histopathology. 2012;61: 387-94.
14. Schwarz S, Zenk J, Muller M, Ettl T, Wunsch PH, Hartmann A, Agaimy A. The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosis. Histopathology. 2012;61: 395-408.
15. Rastatter JC, Jatana KR, Jennings LJ, Melin-Aldana H. Mammary analogue secretory carcinoma of parotid gland in a pediatric patient. Otolaryngol Head Neck Surg. 2012;146: 514-5.
16. Petersson F, Lian D, Chau YP, Yan B. Mammary analogue secretory carcinoma: the first submandibular case reported including findings on fine needle aspiration cytology. Head Neck Pathol. 2012;6: 135-9.
17. Ito S, Ishida E, Skalova A, Matsuura K, Kumamoto H, Sato I. Short communication: a case of mammary analogue secretory carcinoma of parotid gland. Pathol Internat. 2012;62: 149-52.
18. Levine P, Fried K, Krevitt LD, Wang B, Wenig BM. Aspiration biopsy of mammary analogue secretory carcinoma of accessory parotid gland: another diagnostic dilemma in matrix-containing tumors of the salivary glands. Diagn Cytopathol 2012.
19. Kratochvil FJ, Stewart JCB, Moore SR. Mammary analog secretory carcinoma of salivary glands: a report of 2 cases in the lip. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114: 630-5.
20. Laco J, Švajdler M, Jr, Andrejs J, Hrubala D, Hácová M, Vaněček T, Skálová A, Ryška A. Mammary analogue secretory carcinoma of salivary glands: a report of 2 cases with expression of basal/myoepithelial markers (calponin, CD10 and p63 protein). Pathol Res Pract 2013- in press.
21. Chenevert J, Duvvuri U, Chiosea S, Dacic S, Cieply K, Kim J, Shiwarski D, Seethala RR. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol. 2012;25: 919-29.
22. Griffith CC, Stelow EB, Saqi A, Khalbuss WE, Schneider F, Chiosea SI, Seethala R. The cytological features of mammary analogue secretory carcinoma. A series of 6 molecularly confirmed cases. Cancer Cytopathol. 2013;121: 234-41.
23. Tognon CE, Somasiti AM, Evdokimova VE, et al. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway. Cancer Res. 2011;71: 1060-70.
24. Behboudi A, Enlund F, Winnes M, Andrén Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Mäkitie A, Grenman R, Mark J, Stenman G. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer. 2006;45: 470-81.
25. Moller E, Stenman G, Mandahl N, Hamberg H, Molne L, van den Oord JJ, Brosjo O, Mertens F, Panagopoukos I. POU5FI, encoding a key regulator of stem cell pluripotency, is fused to EWSRI in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol. 2008;215: 78-86.
26. Persson M, Andrén Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106: 18740-4.
27. Antonescu C, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan RC, Perez-Ordonez B, Have C, Asa SL, Leong IT, Bradley G, Klieb H, Weinreb I. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer. 2011;50(7): 559-70.